HSIC Stock Analysis: Buy, Sell, or Hold?
HSIC - Henry Schein Inc
$82.84
2.74 (3.42%)
▲
5d:
+2.01%
30d:
+11.63%
90d:
+11.92%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When HSIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSIC shows positive signals but monitor for confirmation. Market pricing in 0.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: HSIC shows positive signals but monitor for confirmation. Market pricing in 0.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$114.29
Based on 7.3% avg growth
INTRINSIC VALUE TODAY
$70.97
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSIC is currently trading at $82.84, which is considered extended relative to its 30-day fair value range of $74.52 to $80.34. The stock's valuation (Forward PE: 13.5) is in line with its historical norms (13.6). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This pessimistic expectation contrasts with the company's recent 4.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, HSIC is in a downtrend. The price is approaching resistance at $80.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSIC is in a downtrend. The price is approaching resistance at $80.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$74.52 -
$80.34
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- NEUTRAL: Near Wall St target ($88.07)
Trading Range Analysis
30-Day Trading Range
$74.52 -
$80.34
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.77
(4.5%)
Support & Resistance Levels
Support Level
$74.38
Resistance Level
$80.83
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.54
Wall Street Target
$88.07
(+9.9%)
Revenue Growth (YoY)
6.3%
Earnings Growth (YoY)
4.5%
Profit Margin
2.9%
Valuation Discount vs History
-0.1% cheaper
PE vs Historical
13.5 vs 13.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.1%
(market-implied from PE analysis)
1-Year Target
$80.02
(0%)
2-Year Target
$79.94
(0%)
3-Year Target
$79.86
(0%)
3-Yr Target (if PE normalizes)
(PE: 14→14)
$80.21
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.6%)
$174.37
(+118%)
Base:
(SPY PE: 13.5, Growth: 10.6%)
$108.41
(+35%)
Bear:
(PE: 11.5, Growth: 10.6%)
$92.15
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 23.77 | Current EPS (TTM): $3.31
Bull Case
$154.66
(+93%)
Analyst growth 78.7%, PE expands to 26.1
Base Case
$140.60
(+76%)
Market implied 78.7%, PE stable at 23.8
Bear Case
$53.50
(-33%)
Severe decline -20.0%, PE contracts to 20.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.5 to 13.6
Stabilization Target:
$80.45
(+0.4%)
PE Expansion Potential:
+0.4%
Share & Embed Analysis
Last updated: June 24, 2026 12:30 PM ET
Data refreshes hourly during market hours. Next update: 1:30 PM
Data refreshes hourly during market hours. Next update: 1:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSIC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-30
Thomas C Popeck
SELL
1355 shares
2026-03-19
Kurt P Kuehn
SELL
2844 shares
2026-03-10
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$941 | 59 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$351 | 62 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$245 | 63 BUY |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced HSIC Option Strategies
Professional options setups generated by AI based on today's HSIC price and gamma walls.
